Ping Cheung Lam
Chairman at MINGYUAN MEDICARE DEVELOPMENT CO., LTD.
Profile
Ping Cheung Lam is the founder of Lam & Co. (Hong Kong).
He is currently the Chairman of Mingyuan Medicare Development Co. Ltd.
He previously served as an Executive Director at Seamless Green China (Holdings) Ltd.
from 2010 to 2011, an Independent Non-Executive Director at Golden Resources Development International Ltd.
from 2011 to 2012, and an Independent Non-Executive Director at Oshidori International Holdings Ltd.
from 2012 to 2015.
He is also a Non-Executive Director at C C Land Holdings Ltd.
Mr. Lam received his undergraduate degree from The Chinese University of Hong Kong in 1977.
Ping Cheung Lam active positions
Companies | Position | Start |
---|---|---|
MINGYUAN MEDICARE DEVELOPMENT CO., LTD. | Chairman | 2016-05-19 |
Former positions of Ping Cheung Lam
Companies | Position | End |
---|---|---|
OSHIDORI INTERNATIONAL HOLDINGS LIMITED | Director/Board Member | 2015-05-20 |
GOLDEN RESOURCES DEVELOPMENT INTERNATIONAL LIMITED | Director/Board Member | 2012-08-29 |
SEAMLESS GREEN CHINA (HOLDINGS) LIMITED | Director/Board Member | 2011-08-03 |
C C LAND HOLDINGS LIMITED | Director/Board Member | 2006-06-21 |
Lam & Co. (Hong Kong) | Founder | - |
Training of Ping Cheung Lam
The Chinese University of Hong Kong | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 4 |
---|---|
SEAMLESS GREEN CHINA (HOLDINGS) LIMITED | Electronic Technology |
GOLDEN RESOURCES DEVELOPMENT INTERNATIONAL LIMITED | Retail Trade |
OSHIDORI INTERNATIONAL HOLDINGS LIMITED | Finance |
C C LAND HOLDINGS LIMITED | Finance |
Private companies | 2 |
---|---|
Mingyuan Medicare Development Co. Ltd.
Mingyuan Medicare Development Co. Ltd. BiotechnologyHealth Technology Mingyuan Medicare Development Co. Ltd. engages in provision of medicare solutions for the early detection and prevention of diseases particularly in China. It operates through the following segments: Protein Chips, Healthcare, Medical Centers Management, Individualized Target Therapy, and Bio-Drugs. The Protein Chips segment manufactures and distributes C-12 products to hospitals, medical centers, and life insurance companies in China. The Healthcare segment engages in the provision of sales and marketing campaign for HPV DNA testing kits and making important progress to register products for distribution to female patients at hospitals nationwide. The Medical Centers Management segment engages in the provision of healthcare services for residents living in cities. The Individualized Target Therapy segment specializes in molecular diagnostic kits for leukemia, lymphoma and individualised target cancer therapy. The Bio-Drugs segment engages in the development, production and commercialization of a new generation of non-specific nanotechnology immunomodulatory drugs known as non-cell Corynebacterium pavum products. The company was founded on May 8, 1989 and is headquartered in Hong Kong. | Health Technology |
Lam & Co. (Hong Kong) |
- Stock Market
- Insiders
- Ping Cheung Lam